Higher target haemoglobin level and early anaemia treatment: Different or complementary concepts?

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 3, 2000, Pages 3-7

  Macdougall, Iain C ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Anaemia; Early treatment; Epoetin; Target haemoglobin; Treatment strategies

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DISEASE COURSE; EXERCISE; HEART DISEASE; HEART FUNCTION; HUMAN; MORBIDITY; PARAMETER; PRIORITY JOURNAL; QUALITY OF LIFE; TISSUE INJURY;

EID: 0033832643     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027974     Document Type: Article

References (28)

1. USA multicenter clinical trial with recombinant human erythropoietin
2. Correction of anaemia of chronic renal failure with recombinant human erythropoietin: Safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients
3. Hemodynamic changes in hemodialyzed patients during treatment with recombinant human erythropoietin
4. Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin
5. Effect of erythropoietin on ischemia tolerance in anemic hemodialysis patients with confirmed coronary artery disease
6. Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients
7. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: A prospective study
8. Working capacity is increased following recombinant human erythropoietin treatment
9. Treatment of anaemia in haemodialysis patients with erythropoietin: Long-term effects on exercise capacity
10. Physical performance and associated electrolyte changes after haemoglobin normalization: A comparative study in haemodialysis patients
11. Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients
12. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin
13. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin
14. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
15. The clinical epidemiology of cardiac disease in chronic renal failure
16. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
17. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
18. Treatment of anemia in hemodialysis patients to a normal hemoglobin concentration-results of an open randomized clinical trial of epoetin beta
19. The Normal Haematocrit Trial in dialysis patients with cardiac disease: Are we any the less confused about target haemoglobin?
20. Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial
21. Effects of r-HuEPO on renal function in chronic renal failure predialysis patients
22. Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass